Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1555
| Despition | TGFBI Human Recombinant, 182 a.a. |
| SIZE | 10 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered liquid formulation. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1536 | Human EFNB1 Protein (AC1536) | 5 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1457 | Rat NME2 Protein (AC1457) | 5 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1037 | Recombinant Human Robo1 Protein (Fc Tag) (AC1037) | 50 µg | inquiry |
| ACPP-1556 | Human SMARCA4 Protein (AC1556) | 5 µg | inquiry |
| ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg | inquiry |
| ACPP-1187 | 5HT1A Blocking Peptide (AC1187) | 250 µg | inquiry |
| ACPP-1119 | CD56 Blocking Peptide (AC1119) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.